Literature DB >> 32532828

Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance.

Ju Yeon Lee1,2, Tujin Shi1, Vladislav A Petyuk1, Athena A Schepmoes1, Thomas L Fillmore1, Yi-Ting Wang1, Wayne Cardoni3, George Coppit3, Shiv Srivastava4,5, Joseph F Goodman6, Craig D Shriver4,5, Tao Liu7, Karin D Rodland7,8.   

Abstract

BACKGROUND: Approximately 85% of the U.S. military active duty population is male and less than 50 years of age, with elevated levels of known risk factors for oropharyngeal squamous cell carcinoma (OPSCC), including smoking, excessive use of alcohol, and greater numbers of sexual partners, and elevated prevalence of human papilloma virus (HPV). Given the recent rise in incidence of OPSCC related to the HPV, the Department of Defense Serum Repository provides an unparalleled resource for longitudinal studies of OPSCC in the military for the identification of early detection biomarkers.
METHODS: We identified 175 patients diagnosed with OPSCC with 175 matched healthy controls and retrieved a total of 978 serum samples drawn at the time of diagnosis, 2 and 4 years prior to diagnosis, and 2 years after diagnosis. Following immunoaffinity depletion, serum samples were analyzed by targeted proteomics assays for multiplexed quantification of a panel of 146 candidate protein biomarkers from the curated literature.
RESULTS: Using a Random Forest machine learning approach, we derived a 13-protein signature that distinguishes cases versus controls based on longitudinal changes in serum protein concentration. The abundances of each of the 13 proteins remain constant over time in control subjects. The AUC for the derived Random Forest classifier was 0.90.
CONCLUSIONS: This 13-protein classifier is highly promising for detection of OPSCC prior to overt symptoms. IMPACT: Use of longitudinal samples has significant potential to identify biomarkers for detection and risk stratification. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32532828     DOI: 10.1158/1055-9965.EPI-20-0192

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  2 in total

Review 1.  Mass spectrometry-based targeted proteomics for analysis of protein mutations.

Authors:  Tai-Tu Lin; Tong Zhang; Reta B Kitata; Tao Liu; Richard D Smith; Wei-Jun Qian; Tujin Shi
Journal:  Mass Spectrom Rev       Date:  2021-10-31       Impact factor: 9.011

2.  Circulating Cancer Biomarkers.

Authors:  Anna Lokshin; Robert C Bast; Karin Rodland
Journal:  Cancers (Basel)       Date:  2021-02-15       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.